Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FGF21 Is a Sugar-Induced Hormone Associated with Sweet Intake and Preference in Humans
Susanna Søberg, Camilla H. Sandholt, Naja Z. Jespersen, et al.
Cell Metabolism (2017) Vol. 25, Iss. 5, pp. 1045-1053.e6
Open Access | Times Cited: 190

Showing 1-25 of 190 citing articles:

Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Naoto Fujiwara, Scott L. Friedman, Nicolas Goossens, et al.
Journal of Hepatology (2017) Vol. 68, Iss. 3, pp. 526-549
Open Access | Times Cited: 603
Physical activity and muscle–brain crosstalk
Bente Klarlund Pedersen
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 7, pp. 383-392
Closed Access | Times Cited: 546
Fibroblast Growth Factor 21—Metabolic Role in Mice and Men
Harald Staiger, Michaela Keuper, Lucia Berti, et al.
Endocrine Reviews (2017) Vol. 38, Iss. 5, pp. 468-488
Open Access | Times Cited: 233
Supra-Additive Effects of Combining Fat and Carbohydrate on Food Reward
Alexandra G. DiFeliceantonio, Géraldine Coppin, Lionel Rigoux, et al.
Cell Metabolism (2018) Vol. 28, Iss. 1, pp. 33-44.e3
Open Access | Times Cited: 231
A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21
Steven A. Kliewer, David J. Mangelsdorf
Cell Metabolism (2019) Vol. 29, Iss. 2, pp. 246-253
Open Access | Times Cited: 215
Metabolic Messengers: FGF21
Kyle H. Flippo, Matthew J. Potthoff
Nature Metabolism (2021) Vol. 3, Iss. 3, pp. 309-317
Open Access | Times Cited: 198
Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study
Charlotte Debras, Eloi Chazelas, Bernard Srour, et al.
PLoS Medicine (2022) Vol. 19, Iss. 3, pp. e1003950-e1003950
Open Access | Times Cited: 194
FGF21 Signals Protein Status to the Brain and Adaptively Regulates Food Choice and Metabolism
Cristal M. Hill, Thomas Laeger, MADELEINE V. DEHNER, et al.
Cell Reports (2019) Vol. 27, Iss. 10, pp. 2934-2947.e3
Open Access | Times Cited: 182
Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis
Lucas D. BonDurant, Matthew J. Potthoff
Annual Review of Nutrition (2018) Vol. 38, Iss. 1, pp. 173-196
Open Access | Times Cited: 176
Therapeutic Landscape for NAFLD in 2020
Brent A. Neuschwander‐Tetri
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1984-1998.e3
Closed Access | Times Cited: 168
FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
Erik J. Tillman, Timothy P. Rolph
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 162
Brown Adipose Crosstalk in Tissue Plasticity and Human Metabolism
Camilla Schéele, Christian Wolfrum
Endocrine Reviews (2019) Vol. 41, Iss. 1, pp. 53-65
Open Access | Times Cited: 151
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 96
Brown Adipose Tissue—A Translational Perspective
André C. Carpentier, Denis P. Blondin, François Haman, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 2, pp. 143-192
Open Access | Times Cited: 96
FGF21: A Novel Regulator of Glucose and Lipid Metabolism and Whole-Body Energy Balance
Ewa Szczepańska, Małgorzata Gietka‐Czernel
Hormone and Metabolic Research (2022) Vol. 54, Iss. 04, pp. 203-211
Open Access | Times Cited: 83
FGF21 agonists: An emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond
Stephen A. Harrison, Timothy P. Rolph, Madeline Knott, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 562-576
Closed Access | Times Cited: 30
FGF-based drug discovery: advances and challenges
Gaozhi Chen, Lingfeng Chen, Xiaokun Li, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
Marie Boyle, Steven Masson, Quentin M. Anstee
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 251-267
Open Access | Times Cited: 140
Going Back to the Biology of FGF21: New Insights
Jo E. Lewis, Francis J. P. Ebling, Ricardo J. Samms, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 8, pp. 491-504
Open Access | Times Cited: 136
Genetic Background of Taste Perception, Taste Preferences, and Its Nutritional Implications: A Systematic Review
Judit Diószegi, Erand Llanaj, Róza Ádány
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 132
Metabolic communication during exercise
Robyn M. Murphy, Matthew J. Watt, Mark A. Febbraio
Nature Metabolism (2020) Vol. 2, Iss. 9, pp. 805-816
Closed Access | Times Cited: 128
The FGF metabolic axis
Xiaokun Li
Frontiers of Medicine (2019) Vol. 13, Iss. 5, pp. 511-530
Open Access | Times Cited: 120
FGF21 Signals to Glutamatergic Neurons in the Ventromedial Hypothalamus to Suppress Carbohydrate Intake
Sharon O. Jensen-Cody, Kyle H. Flippo, Kristin E. Claflin, et al.
Cell Metabolism (2020) Vol. 32, Iss. 2, pp. 273-286.e6
Open Access | Times Cited: 110
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
Christoffer Clemmensen, Brian Finan, Timo D. Müller, et al.
Nature Reviews Endocrinology (2018) Vol. 15, Iss. 2, pp. 90-104
Closed Access | Times Cited: 103
Fibroblast growth factor 21: a regulator of metabolic disease and health span
Ting Xie, Po Sing Leung
AJP Endocrinology and Metabolism (2017) Vol. 313, Iss. 3, pp. E292-E302
Open Access | Times Cited: 92
Page 1 - Next Page

Scroll to top